“Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor”. Journal of Regulatory Science 7 (February 26, 2019): 1–9. Accessed September 17, 2024. https://regsci-ojs-tamu.tdl.org/regsci/article/view/105.